首頁 > 市場調查報告書 > 通訊

人工智能

市場調查報告書

商品編碼

1727707

人工智慧的共同研究及授權契約:2019年～2025年

Artificial Intelligence (AI) Collaboration and Licensing Deals 2019-2025

出版日期: 2025年05月01日 | 出版商:

Current Partnering | 英文 500+ Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

"人工智慧 (AI) 合作與授權協議" 報告提供了前所未有的途徑，讓我們能夠全面了解全球領先生物製藥公司達成的 AI 交易。

這份經過全面修訂和更新的報告詳細介紹了 2019 年至 2025 年的 AI 交易，並深入分析了企業達成 AI 交易的方式和原因。這些交易通常涉及多個領域，從合作研發到成果商業化。

本報告涵蓋了合作、開發、研究和授權交易。

本報告全面列出了自 2019 年以來宣布的 959 筆 AI 交易，包括交易方披露的實際 AI 合作交易的線上交易記錄連結以及財務條款（如有）。此外，報告還包含本公司及其合作夥伴向美國證券交易委員會提交的合約文件（如有）。

本報告第一章介紹了人工智慧交易格局。

第一章是對報告的介紹。

第二章概述了自2019年以來的人工智慧交易趨勢。

第三章概述了自2019年以來的主要人工智慧交易。交易按交易金額排序。

第四章列出了在人工智慧交易中最活躍的25家公司，並進行了簡要總結，隨後是完整的人工智慧交易清單以及公開的合約文件。

第五章對自2019年1月以來簽署和宣布的人工智慧交易進行了全面深入的回顧，其中的合約文件可在公共領域查閱。

第六章對自2019年1月以來簽署和宣布的人工智慧合作交易進行了全面深入的回顧。本章按感興趣的特定人工智慧技術類型進行組織。

本報告也包含大量圖表，展現了2019年及未來的AI交易趨勢和活動。

此外，報告還提供了全面的交易目錄，按公司A-Z、交易類型和治療目標進行整理。每個交易標題都透過網頁連結連結到線上交易記錄，並包含合約文件（如有），方便根據需要輕鬆存取每個合約文件。

主要的優點

"人工智慧 (AI) 合作與授權交易" 為讀者提供以下主要優勢：

了解 2019 年及以後的交易趨勢
瀏覽 AI 合作與授權交易
基準分析 - 確定交易的市場價值
財務條款 - 一次性付款、里程碑付款、特許權使用費
公司 A-Z、交易類型和治療領域分類的交易目錄
以交易價值排序的熱門交易
最活躍的交易撮合者
確定每筆交易的資產和交易條款
存取合約文件 - 深入了解交易結構
盡職調查 - 評估擬議交易條款是否適合您的合作夥伴
節省數百小時的研究時間

調查範圍

人工智慧 "合作與授權協議" 旨在深入了解全球領先生物製藥公司在人工智慧領域的趨勢和交易結構。

人工智慧合作與授權協議包括：

生物製藥產業的人工智慧交易趨勢
涵蓋製藥和生物技術領域的人工智慧交易記錄目錄
主要的人工智慧交易
最活躍的人工智慧授權交易撮合者
"人工智慧合作與授權協議" 提供全面的交易記錄，包括合約文件。

分析合約文件有助於對以下內容進行盡職調查：

授予或選擇的具體權利是什麼？
合約實際上授予了合作公司哪些權利？
授予了哪些獨家權利？
合約的付款結構是怎樣的？
如何審計銷售和付款？
合約期限是多久？
合約的關鍵條款是如何定義的？
如何處理並擁有知識產權？
誰負責商業化？
誰負責開發、供應和製造？
如何管理保密和資訊揭露？
如何解決爭議？
合約在什麼情況下可以終止？
如果所有權發生變更會怎樣？
雙方約定了哪些分授權和分包條款？
公司堅持哪些標準條款？
哪些標準條款似乎因合作夥伴和交易類型的不同而有所差異？
公司在契約法方面主張哪些管轄權？

This report contains a comprehensive listing of 959 artificial intelligence deals announced since 2019 including financial terms where available including links to online deal records of actual artificial intelligence partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of artificial intelligence dealmaking.

Chapter 1 provides an introduction to the report.

Chapter 2 provides an overview of the trends in artificial intelligence dealmaking since 2019.

Chapter 3 provides an overview of the leading artificial intelligence deals since 2019. Deals are listed by headline value.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in artificial intelligence dealmaking with a brief summary followed by a comprehensive listing of artificial intelligence deals, as well as contract documents available in the public domain.

Chapter 5 provides a comprehensive and detailed review of artificial intelligence deals signed and announced since Jan 2019, where a contract document is available in the public domain.

Chapter 6 provides a comprehensive and detailed review of artificial intelligence partnering deals signed and announced since Jan 2019. The chapter is organized by specific artificial intelligence technology type in focus.

The report also includes numerous table and figures that illustrate the trends and activities in artificial intelligence deal making since 2019.

In addition, a comprehensive deal directory is provided organized by company A-Z, deal type and therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Key benefits

Artificial Intelligence (AI) Collaboration and Licensing Deals provides the reader with the following key benefits:

Understand deal trends since 2019
Browse artificial intelligence collaboration and licensing deals
Benchmark analysis - identify market value of transactions
Financials terms - upfront, milestone, royalties
Directory of deals by company A-Z, deal type and therapy area
Leading deals by value
Most active dealmakers
Identify assets and deal terms for each transaction
Access contract documents - insights into deal structures
Due diligence - assess suitability of your proposed deal terms for partner companies
Save hundreds of hours of research time

Report scope

Artificial Intelligence (AI) Collaboration and Licensing Deals is intended to provide the reader with an in-depth understanding of artificial intelligence trends and structure of deals entered into by leading biopharma companies worldwide.

Artificial Intelligence (AI) Collaboration and Licensing Deals includes:

Trends in artificial intelligence dealmaking in the biopharma industry
Directory of artificial intelligence deal records covering pharmaceutical and biotechnology
The leading artificial intelligence deals by value
Most active artificial intelligence licensing dealmakers
Artificial Intelligence (AI) Collaboration and Licensing Deals provides comprehensive access to available records for deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How are sales and payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in artificial intelligence dealmaking

2.1. Introduction
2.2. Artificial intelligence deals over the years
2.3. Most active artificial intelligence dealmakers
2.4. Artificial intelligence deals by deal type
2.5. Artificial intelligence deals by therapy area
2.6. Artificial intelligence deals by industry sector
2.7. Deal terms for artificial intelligence deals
- 2.7.1 Artificial intelligence deals headline values
- 2.7.2 Artificial intelligence deal upfront payments
- 2.7.3 Artificial intelligence deal milestone payments
- 2.7.4 Artificial intelligence royalty rates